Bianca Collings Chief Marketing Officer Bianca Collings is Chief Marketing Officer at Lumea, where she leads GTM strategy, brand, product marketing, and SEO for the U.S. leader in primary clinical…
Read More
Mopec Group, the industry leader of anatomic and forensic pathology equipment and technology, today announced a strategic partnership with Lumea, the leader in digital pathology and AI-powered workflow innovation–advancing efficient,…
Bianca Collings Chief Marketing Officer Bianca Collings is Chief Marketing Officer at Lumea, where she leads GTM strategy, brand, product marketing, and SEO for the U.S. leader in primary clinical…
We’re excited to share that Lumea will be participating as a Technology Partner and Exhibitor at the upcoming Transforming Digital Pathology & AI: The Path Forward conference, taking place on…
The future of pathology isn’t just digital—it’s integrated. As precision medicine continues to advance, the need for seamless coordination between pathology and molecular diagnostics has never been greater. However, traditional…
A Summary of Staci Kearney’s presentation at the Digital Diagnostic Summit 2024 The Current State of the FDA’s Final Rule On May 6, 2024, the FDA issued its final rule…
AI has been a huge buzzword in pathology, but are the benefits worth the hype for prostate cancer? It’s true that AI can enhance digital prostate pathology by supporting diagnostic…
“We’re all doctors. We all got into this field for a reason: the patient is central to everything we do. Using Lumea technology simply results in a better end product…
Join us on PathPulse, the Digital Diagnostic Podcast, as we delve into the groundbreaking journey of Dr. Matthew O. Leavitt, a Stanford-trained pathologist and visionary leader in digital pathology. Host…
The benefits of digital pathology extend well beyond the pathologist’s workstation. When implemented effectively, digital pathology improves outcomes at every point in the diagnostic chain: patients receive faster, more accurate…
